Wednesday, December 5, 2018

USFDA makes 22 observations post inspection of Lupin#39;s Mandideep facilities

USFDA makes 22 observations post inspection of Lupin#39;s Mandideep facilities Lupin#39;s Mandideep location houses the company#39;s cardiovascular Pril API facilities, Cephalosporin API facilities and Cephalosporin solid oral dosage form facility.

from Moneycontrol Business News https://ift.tt/2E1zYrJ

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...